A personalized approach to the management of VWD
(2019) In Transfusion and Apheresis Science 58(5). p.590-595- Abstract
The goal of treating Von Willebrand Disease (VWD) is to replace deficient or dysfunctional Von Willebrand Factor (VWF) protein. However, the choice of treatment has to be considered carefully in view of patient factors and the unique properties of replacement products. Tailoring a treatment plan to an individual patient's bleeding challenge is an intricate process. This review describes personalization of treatment selection for desmopressin (DDAVP), VWF replacement concentrates, including the newly available recombinant VWF (rVWF) and prophylaxis as a treatment approach in VWD.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/244a456b-068e-42fb-ab5c-7e75ddd1ec7b
- author
- Phua, Chai W. and Berntorp, Erik LU
- organization
- publishing date
- 2019-08-07
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Management of von Willebrand Disease, Personalization of von Willebrand Disease, Personalized approach to von Willebrand Disease, Treatment of von Willebrand Disease
- in
- Transfusion and Apheresis Science
- volume
- 58
- issue
- 5
- pages
- 590 - 595
- publisher
- Elsevier
- external identifiers
-
- scopus:85071097870
- pmid:31466808
- ISSN
- 1473-0502
- DOI
- 10.1016/j.transci.2019.08.009
- language
- English
- LU publication?
- yes
- id
- 244a456b-068e-42fb-ab5c-7e75ddd1ec7b
- date added to LUP
- 2019-09-05 16:15:58
- date last changed
- 2024-08-21 06:44:15
@article{244a456b-068e-42fb-ab5c-7e75ddd1ec7b, abstract = {{<p>The goal of treating Von Willebrand Disease (VWD) is to replace deficient or dysfunctional Von Willebrand Factor (VWF) protein. However, the choice of treatment has to be considered carefully in view of patient factors and the unique properties of replacement products. Tailoring a treatment plan to an individual patient's bleeding challenge is an intricate process. This review describes personalization of treatment selection for desmopressin (DDAVP), VWF replacement concentrates, including the newly available recombinant VWF (rVWF) and prophylaxis as a treatment approach in VWD.</p>}}, author = {{Phua, Chai W. and Berntorp, Erik}}, issn = {{1473-0502}}, keywords = {{Management of von Willebrand Disease; Personalization of von Willebrand Disease; Personalized approach to von Willebrand Disease; Treatment of von Willebrand Disease}}, language = {{eng}}, month = {{08}}, number = {{5}}, pages = {{590--595}}, publisher = {{Elsevier}}, series = {{Transfusion and Apheresis Science}}, title = {{A personalized approach to the management of VWD}}, url = {{http://dx.doi.org/10.1016/j.transci.2019.08.009}}, doi = {{10.1016/j.transci.2019.08.009}}, volume = {{58}}, year = {{2019}}, }